Musculoskeletal translational research collaboration

What is the UK MSK TRC?

The UK Musculoskeletal Translational Research Collaboration (UK MSK TRC) is a joint initiative between Versus Arthritis and the National Institute for Health Research (NIHR) for early phase translational research. The collaboration brings together our previous investment in Experimental Arthritis and Osteoarthritis Treatment Centres with the NIHR infrastructure through their relevant Biomedical Research Centres.

By bringing together national expertise in musculoskeletal translational research, the collaboration aims to create a UK-wide ambition and focus to drive cutting edge translational research and will move us closer towards a world free from pain, fatigue and isolation of arthritis. The UK MSK TRC will also provide industry with streamlined access to world leading academic clinicians and scientists with expertise in conditions including:

  • connective tissue diseases
  • inflammatory arthritis
  • osteoarthritis
  • pain

In addition, by providing a network of expertise and a collaboration in which to undertake clinical studies, we hope that this collaboration will stimulate industry activity in musculoskeletal research and will play a role in increasing the investment in musculoskeletal research to levels that equate the scale of the impact of arthritis.

The UK MSK TRC works collaboratively with all sectors of the health and care ecosystem including the life sciences industry, charities and other funders to further research in musculoskeletal disorders and to help develop new diagnostics and treatments. Areas of unmet need are regularly reviewed to determine emerging topics that could become a focus for the group.

Patient and public involvement and engagement is a central theme of the TRC approach, through a strong relationship people with arthritis via both Versus Arthritis and the NIHR.

“By working together, we can accelerate the development of new treatments, devices and diagnostics to tackle complex areas of unmet healthcare needs.”

Peter Taylor, University of Oxford

UK MSK TRC partner organisations

Lead academic Centre
Professor Costantino Pitzalis Barts Health NHS Trust; Queen Mary University of London
Professor David Isenberg University College London Hospitals NHS Foundation Trust; Royal Free London NHS Foundation Trust; University College London
Professor Peter C Taylor Oxford University Hospitals NHS Trust; University of Oxford
Professor John Isaacs The Newcastle upon Tyne Hospitals NHS Foundation Trust; Newcastle University
Professor Ian Bruce Manchester Academic Health Science Centre
Professor Chris Buckley The University of Birmingham; Birmingham/Sandwell/Dudley Hospitals
Dr Natasha Jordan Cambridge University Hospitals NHS Foundation Trust; University of Cambridge
Dr Matthew Pickering Imperial College London; Imperial College Healthcare NHS Trust
Professor Andrew Cope King's Health Partners Academic Health Science Centre
Professor David Walsh Nottingham University Hospitals NHS Trust; University of Nottingham
Professor Maya Buch University of Leeds; Leeds Teaching Hospitals NHS Trust
Professor Chris Edwards University of Southampton; University Hospital Southampton NHS Foundation Trust
Professor Michael Beresford University of Liverpool; EATC4children
Professor Athimalaipet Ramanan Bristol Royal Hospital For Children; EATC4Children
Professor Ernest Choy Cardiff Regional Experimental Arthritis Treatment and Evaluation Centre (CREATE)
Professor Iain McInnes University of Glasgow; Research into Inflammatory Arthritis Centre Versus Arthritis (RACE)

For more details, or to find out how you can collaborate with us, please contact Keith Pugh at